• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Pharmaceutical Focus: A Look at Combination Products

    The Printed World: Additive Manufacturing in Medtech

    The Lost Year: 2020 Year in Review

    Extrusion Evolution

    Little Big Parts: Micromolding Under the Microscope
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Top News
    Freudenberg Medical Expands Injection Molding Operations

    Plitek Adds New Slitting Capacity

    FDA Grants Emergency Use Authorization for COVID-19 Rapid Antibody Fingerstick Test

    PhysIQ Elects Former Naval Vice Admiral to its Advisory Board

    First Heart Failure Patient Treated With Impulse Dynamics' CCM Therapy in Brazil
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Pharmaceutical Focus: A Look at Combination Products

    The Printed World: Additive Manufacturing in Medtech

    The Lost Year: 2020 Year in Review

    Extrusion Evolution

    Little Big Parts: Micromolding Under the Microscope
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Fixing Face Mask Form and Function

    The Heart of the Matter: Trends in Cardiology

    Virtually the Same? The Challenges of Online Conferences

    Digital Health Delivers During a Year for the Ages

    Advanced Technology for Staking and Swaging Medical Plastics
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Qosina Corp.

    PTI Engineered Plastics Inc.

    Medbio LLC

    FUTEK Advanced Sensor Technology Inc.

    Concise Engineering
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    Meeting Critical Ventilator Product Requirements Amid Pandemic

    Impact of COVID-19 on the Medtech Supply Chain

    Finding the Upside to a Challenging Year

    Preparing Your Design Controls for FDA Approval

    A 'Trial and Error' Approach to Micromolded Parts
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Element

    maxon

    MW Life Sciences

    FUTEK Advanced Sensor Technology Inc.

    Spectrum Plastics Group
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • Podcasts
    • Resources
    • eBook
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Breaking News

    FDA Approves Boston Scientific's Ranger Drug-Coated Balloon

    Drug-eluting stent and drug-coated balloon treats patients with peripheral artery disease.

    Related CONTENT
    • CHF Solutions Appoints CEO
    • Katena Products Welcomes New CEO
    • New Company Formed to Develop Peripheral Venous Disease Treatments
    • Medtronic’s Mike Coyle to Lead iRhythm
    • Pandemic May Hinder Growth in Peripheral Drug-Coated Balloon Market
    PR Newswire11.03.20
    Boston Scientific received U.S. Food and Drug Administration (FDA) approval of the Ranger Drug-Coated Balloon, developed for the treatment of patients with peripheral artery disease (PAD) in the superficial femoral artery (SFA) and proximal popliteal artery (PPA).  
     
    Approximately 200 million people around the world are affected by PAD1, a common circulatory problem in which plaque builds up and narrows arteries, consequently reducing blood flow to limbs. The Ranger DCB was designed with a low therapeutic drug dose and proprietary coating which efficiently transfers the drug into the tissue, resulting in high primary patency rates and low systemic drug exposure for patients. The low-profile platform of the balloon also assists clinicians in performing streamlined procedures and navigating through challenging anatomy in order to deliver consistent therapy.
     
    "This approval allows us to bring more treatment options with exceptional outcomes and proven safety to U.S. physicians and their patients who are facing this challenging disease," said Jeff Mirviss, president, Peripheral Interventions, Boston Scientific. "Adding the Ranger DCB to our drug-eluting portfolio, which also includes our Eluvia Drug-Eluting Vascular Stent System, reinforces our commitment to providing differentiated technology with strong clinical evidence that supports data-driven treatment decisions for millions of patients suffering from PAD worldwide."
     
    The FDA approval is based on results from the RANGER II SFA pivotal trial, which evaluated the safety and effectiveness of the Ranger DCB versus standard percutaneous transluminal angioplasty (PTA) for the treatment of patients with PAD in the SFA and PPA. In the randomized controlled trial, both primary endpoints were met:
     
    • The primary safety endpoint of 12-month freedom from major adverse events (MAE) was 94.1 percent for those treated with the Ranger DCB versus 83.5 percent for standard PTA (Pnon-inferiority <0.0001).2
    • Additionally, patients who received therapy with the Ranger DCB had a significantly lower target lesion revascularization rate—a component of MAE—of 5.5 percent in contrast to 16.5 percent observed with standard PTA (p=0.0011), substantially reducing a patient's need for repeat procedures.2
    • The primary efficacy endpoint of 12-month binary primary patency—a measure of the target vessel remaining unobstructed—was 82.9 percent for the Ranger DCB and 66.3 percent for standard PTA (p=0.0017). Primary patency by Kaplan-Meier estimate was 89.8 percent for the Ranger DCB and 74.0 percent for PTA at 12 months (p=0.0005).2
     
    "The Ranger DCB eases deliverability for a wide range of lesion complexities via a low profile platform that is compatible with smaller diameter guidewires and has shown consistent results in multiple randomized controlled trials," said Ravish Sachar, M.D., UNC Rex Hospital Physician-in-Chief for Heart and Vascular services and principal investigator of the RANGER II SFA trial. "For physicians seeking to limit systemic drug loss without compromising outcomes, data demonstrate the Ranger DCB is a safe and effective treatment option."
     
    The Ranger DCB also demonstrated nearly 90 percent primary patency in the investigator-sponsored COMPARE trial3—the first head-to-head prospective, randomized controlled trial to compare two different DCBs. In the trial, the Ranger DCB demonstrated a similar primary patency rate of 88.4 percent to that of the 89.4 percent observed with IN.PACT Admiral Drug-Coated Balloon (Medtronic) by Kaplan-Meier estimate (p=0.81), with a significantly lower drug dose density (2 µg/mm2 paclitaxel versus 3.5 µg/mm2 paclitaxel, respectively).3,4
     
    Boston Scientific expects to initiate a registry of the Ranger DCB and the Eluvia stent in the coming months to gather additional real-world evidence, which will add to the breadth of clinical data collected on these devices to date. The registry is expected to include five years of patient follow-up with an emphasis on enrolling patient populations who have been historically underrepresented in clinical trials studying treatments for PAD. 
     
    The company announced CE mark for the Ranger DCB in 2014 and plans to immediately launch the device in the U.S.
     
    References
    1 Shu J, Santulli G. Update on peripheral artery disease: Epidemiology and evidence-based facts. Atherosclerosis. 2018;275:379-381.
    2 RANGER II SFA Pivotal Trial 12-Month Results presented by Marianne Brodmann, M.D. LINC 2020. 12-Month Primary Endpoints: Binary Primary Patency = 82.9 percent for Ranger DCB and 66.3 percent for PTA (p= <0.0017). Freedom from Major Adverse Events = 94.1 percent for Ranger DCB and 83.5 percent for PTA (p <0.0001)
    3 COMPARE Clinical Trial 12-Month Results presented by Sabine Steiner, M.D. LINC 2020. 12-Month Primary Endpoints: Binary Primary Patency = 83.0 percent for Ranger DCB and 81.5 percent for IN.PACT DCB (p <0.01). Freedom from Major Adverse Events = 91.0 percent for Ranger DCB and 92.6 percent for IN.PACT DCB (p<0.01).
    4 Based on total drug dose for 4mmx60mm or averages for full size matrix per the IN.PACT Admiral Drug-Coated Balloon Instructions for Use, www.medtronic.com and the Ranger Drug-Coated Balloon Instructions for Use.
    Related Searches
    • Cardiovascular
    Related Knowledge Center
    • Cardiovascular
    Suggested For You
    Medtech Matters: Medtronic Medtech Matters: Medtronic's Robotic Surgery Status
    CHF Solutions Appoints CEO CHF Solutions Appoints CEO
    Katena Products Welcomes New CEO Katena Products Welcomes New CEO
    New Company Formed to Develop Peripheral Venous Disease Treatments New Company Formed to Develop Peripheral Venous Disease Treatments
    Medtronic’s Mike Coyle to Lead iRhythm Medtronic’s Mike Coyle to Lead iRhythm
    Pandemic May Hinder Growth in Peripheral Drug-Coated Balloon Market Pandemic May Hinder Growth in Peripheral Drug-Coated Balloon Market
    Medtronic Medtronic's OsteoCool Procedure Shows Significant Pain Relief in Cancer Patients
    Medtronic Launches Pediatric/Neonatal Acute Dialysis Machine Medtronic Launches Pediatric/Neonatal Acute Dialysis Machine
    Patient-Level Data Confirm Safety Profile of Stellarex Low-Dose, Drug-Coated Balloon Patient-Level Data Confirm Safety Profile of Stellarex Low-Dose, Drug-Coated Balloon
    Advanced NanoTherapies Raises $5.3 Million in Seed-Round Financing Advanced NanoTherapies Raises $5.3 Million in Seed-Round Financing
    Thirteen Percent Revenue Shortfall Expected in Capsule Endoscopes Market Thirteen Percent Revenue Shortfall Expected in Capsule Endoscopes Market
    Global Neurovascular Devices Market to Surpass $3.18 Billion by 2027 Global Neurovascular Devices Market to Surpass $3.18 Billion by 2027
    Boston Scientific Recalls, Discontinues LOTUS Edge Aortic Valve Boston Scientific Recalls, Discontinues LOTUS Edge Aortic Valve
    Integer Holdings Corporation Integer Holdings Corporation
    Medtronic Launches InPen with Real-Time Guardian Connect CGM Data Medtronic Launches InPen with Real-Time Guardian Connect CGM Data

    Related Breaking News

    • Cardiovascular
      First Heart Failure Patient Treated With Impulse Dynamics

      First Heart Failure Patient Treated With Impulse Dynamics' CCM Therapy in Brazil

      The Optimizer delivers cardiac contractility modulation therapy, the company’s proprietary technology, to the heart.
      Business Wire 01.21.21

    • Cardiovascular
      Boston Scientific to Acquire Preventice for Up to $925M

      Boston Scientific to Acquire Preventice for Up to $925M

      Acquisition of external cardiac monitoring technologies, services provider to expand rhythm management diagnostics portfolio.
      PR Newswire 01.21.21

    • Cardiovascular | Surgical
      Haemonetics to Acquire Cardiva for Up to $510M

      Haemonetics to Acquire Cardiva for Up to $510M

      Enhances penetration into the large and growing interventional cardiology and electrophysiology markets.
      PR Newswire 01.20.21


    • Cardiovascular | Surgical
      Abbott Wins Expanded Medicare Coverage for MitraClip

      Abbott Wins Expanded Medicare Coverage for MitraClip

      Includes patients with secondary (or functional) mitral regurgitation resulting from heart failure.
      Abbott Laboratories 01.20.21

    • Cardiovascular | Patient Monitoring
      Hillrom to Buy Bardy Diagnostics for $375M

      Hillrom to Buy Bardy Diagnostics for $375M

      Advances digital health offering with expansion into attractive ambulatory cardiac monitoring segment.
      PR Newswire 01.19.21

    • Cardiovascular
      Occlutech

      Occlutech's Atrial Flow Regulator Earns Breakthrough Status for HF

      First-in-class, implantable Atrial Flow Regulator (AFR) for heart failure (HF) patients.
      PR Newswire 01.19.21


    • Cardiovascular | Diagnostics
      FDA OKs MRI for Impulse Dynamics

      FDA OKs MRI for Impulse Dynamics' Optimizer CCM Delivery Systems

      FDA clears potential hurdle for many heart failure patients.
      Business Wire 01.19.21

    • Cardiovascular
      FineHeart Successfully Tests Wireless TET System

      FineHeart Successfully Tests Wireless TET System

      A breakthrough in treating patients with severe heart failure.
      FineHeart 01.18.21

    • Cardiovascular
      U.S. TAVR Market Projected to Reach Nearly $5 Billion by 2030

      U.S. TAVR Market Projected to Reach Nearly $5 Billion by 2030

      The use of TAVR over open surgical techniques for replacing an aortic valve has exploded globally in recent years.
      GlobalData 01.15.21


    • Cardiovascular
      WhiteSwell Issued Patent for Treatment of Acute Decompensated Heart Failure

      WhiteSwell Issued Patent for Treatment of Acute Decompensated Heart Failure

      Company adds to portfolio of 40 patents for catheter-based technology that leverages the power of the body’s natural fluid removal process.
      Business Wire 01.13.21

    • Cardiovascular
      Acutus Medical Launches AcQCross Transseptal System in Europe

      Acutus Medical Launches AcQCross Transseptal System in Europe

      The product is designed to improve safety and efficiency in any procedure requiring left heart access.
      Globe Newswire 01.08.21

    • Cardiovascular | Neurological | Surgical
      FDA OKs Rapid Medical

      FDA OKs Rapid Medical's Steerable Neurovascular Guidewire

      Provides efficient access in difficult neuro and peripheral vascular procedures.
      Business Wire 01.04.21


    • Cardiovascular
      Edwards Treats First Patient in Restore Clinical Trial

      Edwards Treats First Patient in Restore Clinical Trial

      Evaluates minimally invasive device for mitral valve disease.
      Edwards Lifesciences Corp. 12.21.20

    • Cardiovascular | Diagnostics
      Genetesis

      Genetesis' CardioFlux Imaging Tech Gains Breakthrough Status

      Leverages room temperature magnetometers to noninvasively measure heart’s naturally-generated magnetic fields.
      Business Wire 12.16.20

    • Cardiovascular
      Pandemic May Hinder Growth in Peripheral Drug-Coated Balloon Market

      Pandemic May Hinder Growth in Peripheral Drug-Coated Balloon Market

      Percutaneous transluminal angioplasty balloon procedures declined by almost 30 percent in 2020.
      GlobalData 12.15.20


    Trending
    • Telemedicine, Regulatory Changes To Characterize Medtech Industry In 2021
    • Philips Buys Capsule Technologies In $635M Deal
    • Top 10 Trends In The Medical Device And Equipment Industry
    • Haemonetics To Acquire Cardiva For Up To $510M
    • Meeting Critical Ventilator Product Requirements Amid Pandemic
    Breaking News
    • Neurent Medical Closes $25 Million Series B Financing
    • Alcon Releases PRECISION1 for Astigmatism Contact Lenses in U.S.
    • FDA OKs Canon Medical's AI-Powered, 90cm Bore CT
    • Freudenberg Medical Expands Injection Molding Operations
    • Plitek Adds New Slitting Capacity
    View Breaking News >
    CURRENT ISSUE

    November/December 2020

    • Pharmaceutical Focus: A Look at Combination Products
    • The Printed World: Additive Manufacturing in Medtech
    • The Lost Year: 2020 Year in Review
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    FrieslandCampina Launches Biotis Immune Health Ingredient
    Astaxanthin Microencapsulated with Spirulina Targets ‘Mental Agility’ and Healthy Aging
    Ingredient Manufacturers Discuss the E-Sports Market
    Coatings World

    Latest Breaking News From Coatings World

    IGL Coatings Launches Graphene Reinforced Dual System Ceramic Coating
    Miller Paint Declares Simple Serenity its 2021 Color of the Year
    TAUBMANS Paint by PPG Releases ‘Chromatic Joy’ Palettes
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Neurent Medical Closes $25 Million Series B Financing
    Alcon Releases PRECISION1 for Astigmatism Contact Lenses in U.S.
    FDA OKs Canon Medical's AI-Powered, 90cm Bore CT
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Piramal Inks Clinical Supply Deal with Theratechnologies
    Recipharm Signs Manufacturing Deal with Enzymatica
    CDMO Northway Biotech Expands in U.S.
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    TBM Offers New Turnkey Range—Cocoon Skin
    Firmenich Appoints Chief Consumer & Innovation Officer, Global Perfumery
    Top Beauty Brands in the World—And Most Loved Fragrances
    Happi

    Latest Breaking News From Happi

    Ipsy Adds New Personal Care Brand
    John Masters Organics Rolls Out Roll-On Fragrances
    Weleda Celebrates 100 Years of Beauty
    Ink World

    Latest Breaking News From Ink World

    Morancé Soudure France Adds Comexi F2 MC 10-color Flexo Press
    THIMM Group Installs 1st Koenig & Bauer CorruFLEX
    Cowan Graphics Adds Fujifilm Inca OnsetX3 HS
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Lemu Group engineers mask-making machine
    Niagara Label upgrades with Nilpeter flexo press
    Soma partners with Moore & Moore in US
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    P&G Reports 8% Sales Increase
    Wemy Donates PPE to Teaching Hospital
    First Quality Launches Incognito by Prevail
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    SeaSpine Launches Regatta Lateral Plates
    RIVANNA Launches Second-Generation Accuro With Thoracic Functionality
    DJO Acquires Trilliant Surgical
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    UDC Subsidiary Adesis' Website Wins 2020 MarCom Platinum Award
    Roadsimple Modernizes Warehouse Ops with Zebra Technologies
    Graphene Flagship Launches Redesigned Website

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login